4.8 Article

Pax3 and Hippo Signaling Coordinate Melanocyte Gene Expression in Neural Crest

Journal

CELL REPORTS
Volume 9, Issue 5, Pages 1885-1895

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2014.10.061

Keywords

-

Categories

Funding

  1. Spain Fund for Cardiovascular Research
  2. WW Smith Endowed Chair [NIH U01 HL100405]
  3. National Institute of Neurological Disorders and Stroke [1R01NS054794-06]
  4. Defense Advanced Research Projects Agency [DARPA-D12AP00025]
  5. Penn Genome Frontiers Institute under a HRFF grant with the Pennsylvania Department of Health

Ask authors/readers for more resources

Loss of Pax3, a developmentally regulated transcription factor expressed in premigratory neural crest, results in severe developmental defects and embryonic lethality. Although Pax3 mutations produce profound phenotypes, the intrinsic transcriptional activation exhibited by Pax3 is surprisingly modest. We postulated the existence of transcriptional coactivators that function with Pax3 to mediate developmental functions. A high-throughput screen identified the Hippo effector proteins Taz and Yap65 as Pax3 coactivators. Synergistic coactivation of target genes by Pax3-Taz/Yap65 requires DNA binding by Pax3, is Tead independent, and is regulated by Hippo kinases Mst1 and Lats2. In vivo, Pax3 and Yap65 colocalize in the nucleus of neural crest progenitors in the dorsal neural tube. Neural crest deletion of Taz and Yap65 results in embryo-lethal neural crest defects and decreased expression of the Pax3 target gene, Mitf. These results suggest that Pax3 activity is regulated by the Hippo pathway and that Pax factors are Hippo effectors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available